Cormorant Asset Management, LP Q2 2024 Filing
Filed August 14, 2024
Portfolio Value
$1.7T
Holdings
49
Report Date
Q2 2024
Filing Type
13F-HR
All Holdings (49 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | MLTXMOONLAKE IMMUNOTHERAPEUTICS | 8,494,151 | $373.5B | 21.58% | |
| 2 | CRBPCORBUS PHARMACEUTICALS HLDGS | 2,025,000 | $91.6B | 5.29% | |
| 3 | ACLXARCELLX INC | 1,525,000 | $84.2B | 4.86% | |
| 4 | PCVXVAXCYTE INC | 1,100,000 | $83.1B | 4.80% | |
| 5 | —LONGBOARD PHARMACEUTICALS IN | 2,790,462 | $75.4B | 4.36% | |
| 6 | EYPTEYEPOINT PHARMACEUTICALS INC | 8,325,000 | $72.4B | 4.18% | |
| 7 | RAPPRAPPORT THERAPEUTICS INC | 2,940,283 | $68.4B | 3.95% | |
| 8 | CRNXCRINETICS PHARMACEUTICALS IN | 1,350,000 | $60.5B | 3.49% | |
| 9 | EWTXEDGEWISE THERAPEUTICS INC | 3,006,534 | $54.1B | 3.13% | |
| 10 | MRUSMERUS N V | 840,000 | $49.7B | 2.87% | |
| 11 | BBIOBRIDGEBIO PHARMA INC | 1,858,351 | $47.1B | 2.72% | |
| 12 | IM8NINSMED INC | 675,000 | $45.2B | 2.61% | |
| 13 | NAMSNEWAMSTERDAM PHARMA COMPANY | 2,300,000 | $44.2B | 2.55% | |
| 14 | JANXJANUX THERAPEUTICS INC | 1,050,000 | $44.0B | 2.54% | |
| 15 | AXSMAXSOME THERAPEUTICS INC | 400,000 | $32.2B | 1.86% | |
| 16 | CGONCG ONCOLOGY INC | 975,000 | $30.8B | 1.78% | |
| 17 | HLXCHELIX ACQUISITION CORP II | 2,909,000 | $29.7B | 1.72% | |
| 18 | ALMSALUMIS INC | 2,147,400 | $28.6B | 1.65% | |
| 19 | PRAXPRAXIS PRECISION MEDICINES I | 685,000 | $28.3B | 1.64% | |
| 20 | ABVXABIVAX SA | 2,130,000 | $28.2B | 1.63% | |
| 21 | BHVNBIOHAVEN LTD | 801,963 | $27.8B | 1.61% | |
| 22 | URGNUROGEN PHARMA LTD | 1,650,000 | $27.7B | 1.60% | |
| 23 | PHVSPHARVARIS N V | 1,466,460 | $27.6B | 1.59% | |
| 24 | ARQTARCUTIS BIOTHERAPEUTICS INC | 2,525,000 | $23.5B | 1.36% | |
| 25 | SRPTSAREPTA THERAPEUTICS INC | 125,000 | $19.8B | 1.14% | |
| 26 | CGEMCULLINAN THERAPEUTICS INC | 1,125,000 | $19.6B | 1.13% | |
| 27 | RYTMRHYTHM PHARMACEUTICALS INC | 475,000 | $19.5B | 1.13% | |
| 28 | CRGXCARGO THERAPEUTICS INC | 1,182,563 | $19.4B | 1.12% | |
| 29 | YMABUSDY-MABS THERAPEUTICS INC | 1,450,000 | $17.5B | 1.01% | |
| 30 | RNAAVIDITY BIOSCIENCES INC | 425,000 | $17.4B | 1.00% | |
| 31 | BMEABIOMEA FUSION INC | 3,570,872 | $16.1B | 0.93% | |
| 32 | CNTACENTESSA PHARMACEUTICALS PLC | 1,611,600 | $14.6B | 0.84% | |
| 33 | TARSTARSUS PHARMACEUTICALS INC | 500,000 | $13.6B | 0.79% | |
| 34 | SLNSILENCE THERAPEUTICS PLC | 625,000 | $11.9B | 0.69% | |
| 35 | AVBPARRIVENT BIOPHARMA INC | 515,000 | $9.6B | 0.55% | |
| 36 | ENGNENGENE HOLDINGS INC | 1,000,000 | $9.4B | 0.54% | |
| 37 | KRROKORRO BIO INC | 265,826 | $9.0B | 0.52% | |
| 38 | IDYAIDEAYA BIOSCIENCES INC | 245,000 | $8.6B | 0.50% | |
| 39 | IBRXIMMUNITYBIO INC | 1,250,000 | $7.9B | 0.46% | Put |
| 40 | GHRSGH RESEARCH PLC | 593,043 | $6.9B | 0.40% | |
| 41 | LNTHLANTHEUS HLDGS INC | 75,000 | $6.0B | 0.35% | |
| 42 | STOKSTOKE THERAPEUTICS INC | 427,163 | $5.8B | 0.33% | |
| 43 | —MERSANA THERAPEUTICS INC | 2,600,000 | $5.2B | 0.30% | |
| 44 | NGNENEUROGENE INC | 107,344 | $3.9B | 0.23% | |
| 45 | SIGASIGA TECHNOLOGIES INC | 500,000 | $3.8B | 0.22% | Put |
| 46 | VYNEVYNE THERAPEUTICS INC | 1,394,336 | $2.7B | 0.16% | |
| 47 | CMPXCOMPASS THERAPEUTICS INC | 2,030,823 | $2.0B | 0.12% | |
| 48 | VERVVERVE THERAPEUTICS INC | 350,000 | $1.7B | 0.10% | |
| 49 | RAPTEURRAPT THERAPEUTICS INC | 496,750 | $1.5B | 0.09% |